Wright, I.S., Marple, C.D., and Beck, D.F.: Myocardial Infarction: Its Clinical Manifestations and Treatment with Anticoagulants . Grune and Stratton, New York, 1954.
2.
Tulloch, J.A. , and Gilchrist, A.R.: Anticoagulants in treatment of coronary thrombosis. Brit. M. J., 2: 965, 1950.
3.
McCluskie, J.A.W. and Seaton, D.A.: The value of anticoagulant therapy in the treatment of acute myocardial infarction. Scot. M. J., 4: 305, 1959.
Owren, P. A. Thrombotest: A new method for controlling anticoagulant therapy. Lancet, 2: 754, 1959.
6.
Sevitt, S., and Innes, D.: Prothrombin time and Thrombotest in injured patients on prophylactic anticoagulant therapy. Lancet, 1: 124, 1964.
7.
Quick, A.J.: The prothrombin in haemophilia and obstructive jaundice. J. Biol. Chem., 109: Lxxiii, 1935 .
8.
Mayer, G.A.: Efficiency of the house staff in the management of anticoagulant therapy. Vascular Dis., 2: 30, 1965.
9.
Connell, W.F., and Mayer, G.A.: The relationship of adequate anticoagulant therapy to the prognosis of acute myocardial infarction. International Anticoagulant Symposium, Miami Beach, Florida, 1964 .
10.
Murphy, E.A., Downie, H.G., Rowsell, H.C., and Mustard, J.F.: The effect of Dicumarol and heparin therapy on platelet economy. The relationship of these changes to thrombus formation. International Symposium: Anticoagulants and Fibrinolysis, p. 68. The Macmillan Co. of Canada, Toronto, 1961.
11.
Davies, D.W. : Coagulation tests in anticoagulant therapy. M. J. Australia, 1: 150, 1965.